WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 3.20.
Share Price | ₹1,063.5 | Dec 11,2024 |
Market Cap | ₹2,222.6 Cr | |
Sales-TTM | ₹695.7 Cr | TTM-Consolidated Results |
Price/Sales | 3.20x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,222.6 Cr] as on Dec 11,2024
(/) Sales [ ₹695.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.20x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '3.20 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.72x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2024 at 1.69x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WINDLAS BIOTECH | 695.7 | 3.20 | 2,222.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.65 | 435,407.0 |
CIPLA LTD | 26,512.0 | 4.43 | 117,443.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.43 | 103,338.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.62 | 99,244.9 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.28 | 157,489.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.54 | 105,098.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.17 | 114,202.0 |
LUPIN LTD | 21,431.3 | 4.58 | 98,055.1 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.35 | 71,188.9 |
ABBOTT INDIA LTD | 6,066.1 | 10.11 | 61,336.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.35x |
Max industry PS | 18.28x |
Median industry PS | 4.62x |
Average industry PS | 7.22x |
You may also like the below Video Courses